Adaikkan C, Taha E, Barrera I, David O, Rosenblum K (2018) Calcium/Calmodulin-Dependent protein kinase II and eukaryotic elongation factor 2 kinase pathways mediate the antidepressant action of ketamine. Biol Psychiatry 84(1):65–75. https://doi.org/10.1016/j.biopsych.2017.11.028

Article  CAS  PubMed  Google Scholar 

Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng P, Kavalali ET, Monteggia LM (2011) NMDA receptor Blockade at rest triggers rapid behavioural antidepressant responses. Nature 475(7354):91–95. https://doi.org/10.1038/nature10130

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bayer K-U, De Koninck P, Leonard AS, Hell JW, Schulman H (2001) Interaction with the NMDA receptor locks camkii in an active conformation. Nature 411(6839):801–805. https://doi.org/10.1038/35081080

Article  CAS  PubMed  Google Scholar 

Björkholm C, Monteggia LM (2016) BDNF– a key transducer of antidepressant effects. Neuropharmacology 102:72–79. https://doi.org/10.1016/j.neuropharm.2015.10.034

Article  CAS  PubMed  Google Scholar 

Burgdorf J, Zhang X, Nicholson KL, Balster RL, Leander D, Stanton J, Gross PK, Kroes AL, R. A., Moskal JR (2013) GLYX-13, a NMDA receptor Glycine-Site functional partial agonist, induces Antidepressant-Like effects without Ketamine-Like side effects. Neuropsychopharmacology 38(5):729–742. https://doi.org/10.1038/npp.2012.246

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burgdorf J, Zhang X-l, Weiss C, Gross A, Boikess SR, Kroes RA, Khan MA, Burch RM, Rex CS, Disterhoft JF, Stanton PK, Moskal JR (2015) The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus. Neuroscience 308:202–211. https://doi.org/10.1016/j.neuroscience.2015.09.004

Article  CAS  PubMed  Google Scholar 

Coultrap SJ, Vest RS, Ashpole NM, Hudmon A, Bayer KU (2011) CaMKII in cerebral ischemia. Acta Pharmacol Sin 32(7):861–872. https://doi.org/10.1038/aps.2011.68

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Bartolomeis A, Sarappa C, Buonaguro EF, Marmo F, Eramo A, Tomasetti C, Iasevoli F (2013) Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis. Prog Neuropsychopharmacol Biol Psychiatry 46:1–12. https://doi.org/10.1016/j.pnpbp.2013.06.010

Article  CAS  PubMed  Google Scholar 

Deng G, Orfila JE, Dietz RM, Moreno-Garcia M, Rodgers KM, Coultrap SJ, Quillinan N, Traystman RJ, Bayer KU, Herson PS (2017) Autonomous camkii activity as a drug target for histological and functional neuroprotection after resuscitation from cardiac arrest. Cell Rep 18(5):1109–1117. https://doi.org/10.1016/j.celrep.2017.01.011

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deyama S, Duman RS (2020) Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine. Pharmacol Biochem Behav 188:172837. https://doi.org/10.1016/j.pbb.2019.172837

Article  CAS  PubMed  Google Scholar 

Duman RS (2018) Ketamine and rapid-acting antidepressants: A new era in the battle against depression and suicide. In F1000Research (Vol. 7). F1000 Research Ltd. https://doi.org/10.12688/f1000research.14344.1

Gideons ES, Kavalali ET, Monteggia LM (2014) Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses. Proc Natl Acad Sci 111(23):8649–8654. https://doi.org/10.1073/pnas.1323920111

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heckman PRA, Blokland A, Bollen EPP, Prickaerts J (2018) Phosphodiesterase Inhibition and modulation of corticostriatal and hippocampal circuits: clinical overview and translational considerations. Neurosci Biobehavioral Reviews 87:233–254. https://doi.org/10.1016/j.neubiorev.2018.02.007

Article  CAS  Google Scholar 

Herold S, Jagasia R, Merz K, Wassmer K, Lie DC (2011) CREB signalling regulates early survival, neuronal gene expression and morphological development in adult subventricular zone neurogenesis. Mol Cell Neurosci 46(1):79–88. https://doi.org/10.1016/j.mcn.2010.08.008

Article  CAS  PubMed  Google Scholar 

Kato T, Duman RS (2020) Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: convergent mechanisms. Pharmacol Biochem Behav 188:172827. https://doi.org/10.1016/j.pbb.2019.172827

Article  CAS  PubMed  Google Scholar 

Kato T, Fogaça MV, Deyama S, Li X-Y, Fukumoto K, Duman RS (2018) BDNF release and signaling are required for the antidepressant actions of GLYX-13. Mol Psychiatry 23(10):2007–2017. https://doi.org/10.1038/mp.2017.220

Article  CAS  PubMed  Google Scholar 

Kavalali ET, Monteggia LM (2012) Synaptic mechanisms underlying rapid antidepressant action of ketamine. Am J Psychiatry 169(11):1150–1156. https://doi.org/10.1176/appi.ajp.2012.12040531

Article  PubMed  Google Scholar 

Lepack AE, Fuchikami M, Dwyer JM, Banasr M, Duman RS (2015) BDNF release is required for the behavioral actions of ketamine. Int J Neuropsychopharmacol 18(1):pyu033. https://doi.org/10.1093/ijnp/pyu033

Article  CAS  Google Scholar 

Lepack AE, Bang E, Lee B, Dwyer JM, Duman RS (2016) Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures. Neuropharmacology 111:242–252. https://doi.org/10.1016/j.neuropharm.2016.09.011

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu R-J, Lee FS, Li X-Y, Bambico F, Duman RS, Aghajanian GK (2012) Brain-Derived neurotrophic factor Val66Met allele impairs basal and Ketamine-Stimulated synaptogenesis in prefrontal cortex. Biol Psychiatry 71(11):996–1005. https://doi.org/10.1016/j.biopsych.2011.09.030

Article  CAS  PubMed  Google Scholar 

Liu R-J, Duman C, Kato T, Hare B, Lopresto D, Bang E, Burgdorf J, Moskal J, Taylor J, Aghajanian G, Duman RS (2017) GLYX-13 produces rapid antidepressant responses with key synaptic and behavioral effects distinct from ketamine. Neuropsychopharmacology 42(6):1231–1242. https://doi.org/10.1038/npp.2016.202

Article  CAS  PubMed  Google Scholar 

Liu H, Gong X-D, Zhao X, Qian Y, Gu X-P, Xia T-J (2020) GLYX-13 pretreatment ameliorates long-term isoflurane exposure-induced cognitive impairment in mice. Neural Regeneration Res, 15(1). https://journals.lww.com/nrronline/fulltext/2020/15010/glyx_13_pretreatment_ameliorates_long_term.29.aspx

Maeng, S., Zarate Jr, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., &Manji, H. K. (2008). Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors.Biological Psychiatry, 63(4), 349–352. https://doi.org/10.1016/j.biopsych.2007.05.028

Matveychuk D, Rejish T, Swainson K, Jennifer, Khullar A, MacKay M-A, Glen B B, Dursun SM (2020) Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers. Therapeutic Adv Psychopharmacol 10:2045125320916657. https://doi.org/10.1177/2045125320916657

Article  CAS  Google Scholar 

McIntyre RS, Alsuwaidan M, Baune BT, Berk M, Demyttenaere K, Goldberg JF, Gorwood P, Ho R, Kasper S, Kennedy SH, Ly-Uson J, Mansur RB, McAllister-Williams RH, Murrough JW, Nemeroff CB, Nierenberg AA, Rosenblat JD, Sanacora G, Schatzberg AF, Maj M (2023) Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry 22(3):394–412. https://doi.org/10.1002/wps.21120

Article  PubMed  PubMed Central  Google Scholar 

Miller OH, Yang L, Wang C-C, Hargroder EA, Zhang Y, Delpire E, Hall BJ (2014) GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine. ELife 3:e03581. https://doi.org/10.7554/eLife.03581

Article  PubMed  PubMed Central  Google Scholar 

Monteggia LM, Gideons E, Kavalali ET (2013) The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine. Biol Psychiatry 73(12):1199–1203. https://doi.org/10.1016/j.biopsych.2012.09.006

Article  CAS  PubMed  Google Scholar 

Nahum-Levy R, Lipinski D, Shavit S, Benveniste M (2001) Desensitization of NMDA receptor channels is modulated by glutamate agonists. Biophys J 80(5):2152–2166. https://doi.org/10.1016/S0006-3495(01)76188-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sanhueza M, Fernandez-Villalobos G, Stein IS, Kasumova G, Zhang P, Bayer KU, Otmakhov N, Hell JW, Lisman J (2011) Role of the CaMKII/NMDA receptor complex in the maintenance of synaptic strength. J Neurosci 31(25):9170.